TARO - Taro Pharmaceutical EPS misses by $0.15 misses on revenue January, 27 2021 05:52 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical (TARO): Q4 GAAP EPS of $0.86 misses by $0.15.Revenue of $140.1M (-19.9% Y/Y) misses by $12.53M.Press Release For further details see: Taro Pharmaceutical EPS misses by $0.15, misses on revenue